Valirx (VAL)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 9.25p
   
  • Change Today:
      0.000p
  • 52 Week High: 25.75
  • 52 Week Low: 8.90
  • Currency: UK Pounds
  • Shares Issued: 102.32m
  • Volume: 232,453
  • Market Cap: 9.46m
  • RiskGrade: 435

Financial Analysis

Select chart: EPS | Dividend | Revenue

Latest Interim/Quarterly

Period Ending Period Revenue (m) Pre-tax (m) EPS Dividend
30-Jun-22 Interim n/a (1.07) (1.53)p n/a

Key Fundamentals

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-17 n/a (3.55) (237.50)p n/a n/a n/a n/a 0.0%
31-Dec-18 n/a (4.83) (117.50)p n/a n/a n/a n/a 0.0%
31-Dec-19 n/a (2.72) (4,135.00)p n/a n/a n/a n/a 0.0%
31-Dec-20 n/a (1.54) (3.81)p n/a n/a n/a n/a 0.0%
31-Dec-21 n/a (1.68) (2.34)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Forecasts

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-22 n/a (1.96) (2.67)p n/a n/a n/a n/a 0.0%
31-Dec-23 n/a (2.02) (1.86)p n/a n/a n/a n/a 0.0%

Copyright © 2023 FactSet Research Systems Inc. All rights reserved.

Price / Earnings Data

5 Yr High 5 Yr Low 5 Yr Avg Curr / Avg
Latest n/a n/a n/a 0

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

IFRS Changes - Find Out More

Find out about IFRS and how this affects the financial infomation for all UK companies.

Valirx Market Data

Currency UK Pounds
Share Price 9.25p
Change Today 0.000p
% Change 0.00 %
52 Week High 25.75
52 Week Low 8.90
Volume 232,453
Shares Issued 102.32m
Market Cap 9.46m
RiskGrade 435

Valirx Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
40.93% below the market average40.93% below the market average40.93% below the market average40.93% below the market average40.93% below the market average
13.33% below the sector average13.33% below the sector average13.33% below the sector average13.33% below the sector average13.33% below the sector average
Price Trend
83.5% below the market average83.5% below the market average83.5% below the market average83.5% below the market average83.5% below the market average
63.93% below the sector average63.93% below the sector average63.93% below the sector average63.93% below the sector average63.93% below the sector average
Income Not Available
Growth Not Available

What The Brokers Say

Strong Buy 0
Buy 1
Neutral 0
Sell 0
Strong Sell 0
Total 1
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Valirx Dividends

No dividends found

Trades for 26-May-2023

Time Volume / Share Price
16:20 11,154 @ 9.05p
16:20 4,436 @ 9.02p
15:47 2,000 @ 9.18p
15:36 135,308 @ 9.00p
14:08 19,312 @ 9.05p

Valirx Key Personnel

CFO Gerald Desler
CEO Suzanne Dilly

Top of Page